Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Return on Invested Capital (2019 - 2025)

Inspire Medical Systems' Return on Invested Capital history spans 7 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 11.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, up 11.0%, while the annual FY2025 figure was 0.15%, 10.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.16% at Inspire Medical Systems, up from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.16% in Q4 2025 and bottomed at 0.25% in Q1 2021.
  • The 5-year median for Return on Invested Capital is 0.1% (2022), against an average of 0.08%.
  • The largest annual shift saw Return on Invested Capital increased 2bps in 2022 before it grew 14bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.18% in 2021, then surged by 44bps to 0.1% in 2022, then increased by 23bps to 0.08% in 2023, then skyrocketed by 162bps to 0.05% in 2024, then soared by 227bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for INSP's Return on Invested Capital are 0.16% (Q4 2025), 0.05% (Q3 2025), and 0.06% (Q2 2025).